A H Calvert

Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361

Christopher Calabrese, Robert J. Almassy, Stephen Barton et al. · JNCI Journal of the National Cancer Institute · 2004 · 485 citations · Full text

Medicine, Oncology, Pharmacology +15

Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441

Yan Zhao, Huw D. Thomas, Michael A. Batey et al. · Cancer Research · 2006 · 447 citations · Full text

Medicine, Oncology, Pharmacology +16

ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.

A.L. Jackman, G A Taylor, William Gibson et al. · PubMed · 1991 · 359 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy.

Clet Niyikiza, Sharyn D. Baker, David E. Seitz et al. · PubMed · 2002 · 247 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice

Terence R. Jones, A H Calvert, Ann L. Jackman et al. · European Journal of Cancer (1965) · 1981 · 239 citations

Life Sciences, Medicinal Chemistry, Pharmacology +7